Early stage follicular lymphoma: What is the clinical impact of the first-line treatment strategy?

Journal of Hematology and Oncology

Volumn 6, Issue 1, 2013, Pages

  Michallet, Anne Sophie A S ^a   Lebras, Laure L ^a,b   Bauwens, Deborah D ^c   Bouafia Sauvy, Fadhela F ^a   Berger, Françoise F ^a   Tychyj Pinel, Christelle C ^a   D'Hombres, Anne A ^a   Salles, Gilles G ^a,b   Coiffier, Bertrand B ^a,b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Chemotherapy; Complete response; Follicular lymphoma; Radiotherapy; Rituximab

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; LACTATE DEHYDROGENASE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; DISEASE SEVERITY; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODAL CHEMOTHERAPY; OUTCOME ASSESSMENT; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RETROSPECTIVE STUDY; WATCHFUL WAITING;

AGED; CHEMORADIOTHERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOTHERAPY; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84879490270     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-6-45     Document Type: Article

References (26)

1. Follicular lymphoma: management options in the era of targeted therapy. Peterson CG, Kahl BS, Current treatment options in oncology 2005 6 297 308 10.1007/s11864-005-0034-x 15967083 (Pubitemid 41223384)
2. Long-term results with radiotherapy for Stage I-II follicular lymphomas. Wilder RB, Jones D, Tucker SL, et al. International journal of radiation oncology, biology, physics 2001 51 1219 1227 10.1016/S0360-3016(01)01747-3 11728680 (Pubitemid 33116314)
3. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. Mac Manus MP, Hoppe RT, Journal of clinical oncology: official journal of the American Society of Clinical Oncology 1996 14 1282 1290 (Pubitemid 26105537)
4. Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy. Vaughan Hudson B, Vaughan Hudson G, MacLennan KA, et al. British journal of cancer 1994 69 1088 1093 10.1038/bjc.1994.213 8198975 (Pubitemid 24161865)
5. Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Yahalom J, Varsos G, Fuks Z, et al. Results of a prospective randomized study. Cancer 1993 71 2342 2350 (Pubitemid 23087778)
6. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma. Seymour JF, Pro B, Fuller LM, et al. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2003 21 2115 2122 10.1200/JCO.2003.07.111 (Pubitemid 46606360)
7. Is there any place for a wait-and-see policy in stage I0 follicular lymphoma? A study of 43 consecutive patients in a single center. Soubeyran P, Eghbali H, Trojani M, et al. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO 1996 7 713 718 10.1093/ oxfordjournals.annonc.a010720 (Pubitemid 26323544)
8. Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy. Advani R, Rosenberg SA, Horning SJ, Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2004 22 1454 1459 10.1200/JCO.2004.10.086 (Pubitemid 41103628)
9. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Dreyling M, Annals of oncology: official journal of the European Society for Medical Oncology/ESMO 2010 21 Suppl 5 & 22181 183
10. Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation. Barosi G, Carella A, Lazzarino M, et al. Haematologica 2005 90 1236 1257 16154848 (Pubitemid 41379052)
11. Improved survival in patients with early stage low-grade follicular lymphoma treated with radiation: a Surveillance, Epidemiology, and End Results database analysis. Pugh TJ, Ballonoff A, Newman F, Rabinovitch R, Cancer 2010 116 3843 3851 10.1002/cncr.25149 20564102
12. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Dreyling M, Ghielmini M, Marcus R, et al. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO 2011 22 Suppl 6 & 22i59 63
13. Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. Bastion Y, Sebban C, Berger F, et al. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 1997 15 1587 1594 (Pubitemid 27167397)
14. Follicular lymphoma: time for a re-think? Gandhi MK, Marcus RE, Blood reviews 2005 19 165 178 10.1016/j.blre.2004.09.001 15748964 (Pubitemid 40326199)
15. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma. Kamath SS, Marcus RB Jr, Lynch JW, Mendenhall NP, International journal of radiation oncology, biology, physics 1999 44 563 568 10.1016/S0360-3016(99)00051-6 10348285 (Pubitemid 29258430)
16. Long-term outcome and mortality trends in early-stage, Grade 1-2 follicular lymphoma treated with radiation therapy. Guadagnolo BA, Li S, Neuberg D, et al. International journal of radiation oncology, biology, physics 2006 64 928 934 10.1016/j.ijrobp.2005.08.010 16243446 (Pubitemid 43183595)
17. Long-term outcomes for patients with limited stage follicular lymphoma: involved regional radiotherapy versus involved node radiotherapy. Campbell BA, Voss N, Woods R, et al. Cancer 2010 116 3797 3806 10.1002/cncr.25117 20564082
18. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Lowry L, Smith P, Qian W, et al. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology 2011 100 86 92 10.1016/j.radonc.2011.05.013
19. Treatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a prospective multicenter Phase II trial-MIR trial. Witzens-Harig M, Hensel M, Unterhalt M, Herfarth K, BMC cancer 2011 11 87 10.1186/1471-2407-11-87 21352561
20. A British National Lymphoma Investigation randomised trial of single agent chlorambucil plus radiotherapy versus radiotherapy alone in low grade, localised non-Hodgkins lymphoma. Kelsey SM, Newland AC, Hudson GV, Jelliffe AM, Medical oncology 1994 11 19 25 10.1007/BF02990087 7921924 (Pubitemid 24266261)
21. Effectiveness of First-Line Management Strategies for Stage I Follicular Lymphoma: Analysis of the National LymphoCare Study. Friedberg JW, Byrtek M, Link BK, et al. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2012 30 3368 3375 10.1200/JCO.2011.40.6546
22. Solal-Celigny P, Bellei M, Marcheselli L, et al. Watchful Waiting in Low-Tumor Burden Follicular Lymphoma in the Rituximab Era official journal of the American Society of Clinical Oncology: Results of an F2-Study Database. Journal of clinical oncology 2012
23. Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis. Schulz H, Bohlius JF, Trelle S, et al. Journal of the National Cancer Institute 2007 99 706 714 10.1093/jnci/djk152 17470738 (Pubitemid 47078732)
24. Management of localized-stage follicular lymphoma: changing the paradigm? Montoto S, Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2012 30 3328 3329 10.1200/JCO.2012.43.5768
25. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Ott G, Katzenberger T, Lohr A, et al. Blood 2002 99 3806 3812 10.1182/blood.V99.10.3806 11986240 (Pubitemid 34534555)
26. Follicular lymphoma international prognostic index. Solal-Celigny P, Roy P, Colombat P, et al. Blood 2004 104 1258 1265 10.1182/blood-2003-12-4434 15126323 (Pubitemid 39166497)